• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

替诺福韦酯富马酸盐:小鼠口服给药13周后的毒性、毒代动力学及毒理基因组学分析

Tenofovir disoproxil fumarate: toxicity, toxicokinetics, and toxicogenomics analysis after 13 weeks of oral administration in mice.

作者信息

Ng Hanna H, Stock Howard, Rausch Linda, Bunin Deborah, Wang Abraham, Brill Shirley, Gow Jason, Mirsalis Jon C

机构信息

Biosciences Division, SRI International, Menlo Park, CA, USA

Biosciences Division, SRI International, Menlo Park, CA, USA.

出版信息

Int J Toxicol. 2015 Jan-Feb;34(1):4-10. doi: 10.1177/1091581814565669. Epub 2015 Jan 7.

DOI:10.1177/1091581814565669
PMID:25568137
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4334733/
Abstract

Tenofovir disoproxil fumarate (TDF) is a prodrug of tenofovir that exhibits activity against HIV and hepatitis B. The goals of this study were to evaluate the molecular mechanism of TDF-induced toxicity in mice after 13 weeks of daily oral administration (50-1000 mg/kg) by correlating transcriptional changes with plasma drug levels and traditional toxicology end points. Plasma levels and systemic exposure of tenofovir increased less than dose proportionally and were similar on days 1 and 91. No overt toxicity was observed following the completion of TDF administration. The kidneys of TDF-treated mice were histopathologically normal. This result is consistent with the genomic microarray results, which showed no significant differences in kidney transcriptional levels between TDF-treated animals and controls. In liver, after 4 and 13 weeks, cytomegaly was observed in mice treated with 1000 mg/kg of TDF, but mice recovered from this effect following cessation of administration. Analysis of liver transcripts on day 91 reported elevated levels of Cdkn1a in TDF-treated animals compared with controls, which may have contributed to the inhibition of liver cell cycle progression.

摘要

富马酸替诺福韦二吡呋酯(TDF)是替诺福韦的前体药物,对HIV和乙型肝炎具有活性。本研究的目的是通过将转录变化与血浆药物水平及传统毒理学终点相关联,评估每日口服给药(50 - 1000 mg/kg)13周后TDF在小鼠中诱导毒性的分子机制。替诺福韦的血浆水平和全身暴露量的增加与剂量不成正比,且在第1天和第91天相似。完成TDF给药后未观察到明显毒性。经TDF处理的小鼠肾脏在组织病理学上正常。这一结果与基因组微阵列结果一致,该结果显示经TDF处理的动物与对照动物的肾脏转录水平无显著差异。在肝脏中,4周和13周后,用1000 mg/kg TDF处理的小鼠出现细胞肿大,但停药后小鼠从这种效应中恢复。第91天对肝脏转录本的分析报告显示,与对照相比,经TDF处理的动物中Cdkn1a水平升高,这可能导致了肝细胞周期进程的抑制。

相似文献

1
Tenofovir disoproxil fumarate: toxicity, toxicokinetics, and toxicogenomics analysis after 13 weeks of oral administration in mice.替诺福韦酯富马酸盐:小鼠口服给药13周后的毒性、毒代动力学及毒理基因组学分析
Int J Toxicol. 2015 Jan-Feb;34(1):4-10. doi: 10.1177/1091581814565669. Epub 2015 Jan 7.
2
Association of higher plasma vitamin D binding protein and lower free calcitriol levels with tenofovir disoproxil fumarate use and plasma and intracellular tenofovir pharmacokinetics: cause of a functional vitamin D deficiency?较高的血浆维生素 D 结合蛋白和较低的游离骨化三醇水平与替诺福韦二吡呋酯的使用以及血浆和细胞内替诺福韦药代动力学相关:这是功能性维生素 D 缺乏的原因吗?
Antimicrob Agents Chemother. 2013 Nov;57(11):5619-28. doi: 10.1128/AAC.01096-13. Epub 2013 Sep 3.
3
Pharmacokinetics and pharmacodynamics of the reverse transcriptase inhibitor tenofovir and prophylactic efficacy against HIV-1 infection.逆转录酶抑制剂替诺福韦的药代动力学和药效学及其预防 HIV-1 感染的功效。
PLoS One. 2012;7(7):e40382. doi: 10.1371/journal.pone.0040382. Epub 2012 Jul 11.
4
Pharmacokinetics and dosing recommendations of tenofovir disoproxil fumarate in hepatic or renal impairment.富马酸替诺福韦二吡呋酯在肝损伤或肾损伤患者中的药代动力学及给药建议
Clin Pharmacokinet. 2006;45(11):1115-24. doi: 10.2165/00003088-200645110-00005.
5
Pharmacokinetics of antiretroviral regimens containing tenofovir disoproxil fumarate and atazanavir-ritonavir in adolescents and young adults with human immunodeficiency virus infection.含富马酸替诺福韦二吡呋酯和阿扎那韦-利托那韦的抗逆转录病毒方案在青少年和年轻成人人类免疫缺陷病毒感染者中的药代动力学。
Antimicrob Agents Chemother. 2008 Feb;52(2):631-7. doi: 10.1128/AAC.00761-07. Epub 2007 Nov 19.
6
Pilot pharmacokinetic study of human immunodeficiency virus-infected patients receiving tenofovir disoproxil fumarate (TDF): investigation of systemic and intracellular interactions between TDF and abacavir, lamivudine, or lopinavir-ritonavir.接受富马酸替诺福韦二吡呋酯(TDF)的人类免疫缺陷病毒感染患者的药代动力学初步研究:TDF与阿巴卡韦、拉米夫定或洛匹那韦-利托那韦之间的全身和细胞内相互作用研究
Antimicrob Agents Chemother. 2009 May;53(5):1937-43. doi: 10.1128/AAC.01064-08. Epub 2009 Mar 9.
7
Systemic and renal pharmacokinetics of adefovir and tenofovir upon coadministration.阿德福韦与替诺福韦合用时的全身及肾脏药代动力学。
J Clin Pharmacol. 2005 Aug;45(8):935-40. doi: 10.1177/0091270005278949.
8
Tenofovir renal proximal tubular toxicity is regulated by OAT1 and MRP4 transporters.替诺福韦的肾近端肾小管毒性受 OAT1 和 MRP4 转运体调节。
Lab Invest. 2011 Jun;91(6):852-8. doi: 10.1038/labinvest.2011.48. Epub 2011 Mar 14.
9
Pharmacokinetics and safety of single-dose tenofovir disoproxil fumarate and emtricitabine in HIV-1-infected pregnant women and their infants.富马酸替诺福韦二吡呋酯和恩曲他滨单剂量在感染 HIV-1 的孕妇及其婴儿中的药代动力学和安全性。
Antimicrob Agents Chemother. 2011 Dec;55(12):5914-22. doi: 10.1128/AAC.00544-11. Epub 2011 Sep 6.
10
Nucleotide analogue prodrug tenofovir disoproxil enhances lymphoid cell loading following oral administration in monkeys.核苷酸类似物前药替诺福韦酯在猴子口服给药后可增强淋巴细胞摄取。
Mol Pharm. 2009 Jul-Aug;6(4):1145-51. doi: 10.1021/mp900036s.

引用本文的文献

1
Building Metabolically Stable and Potent Anti-HIV Thioether-Lipid Analogues of Tenofovir Exalidex: A thorough Pharmacological Analysis.构建代谢稳定且强效的抗 HIV 硫醚脂质类似物替诺福韦艾拉酚胺:全面的药理学分析。
J Med Chem. 2024 Oct 24;67(20):18204-18220. doi: 10.1021/acs.jmedchem.4c01510. Epub 2024 Oct 16.
2
Synthesis of Fluorinated Nucleosides/Nucleotides and Their Antiviral Properties.氟代核苷/核苷酸的合成及其抗病毒性质。
Molecules. 2024 May 19;29(10):2390. doi: 10.3390/molecules29102390.
3
Histomorphometric changes in testis following administration of tenofovir nanoparticles in an animal model.

本文引用的文献

1
Extrahepatic effects of nucleoside and nucleotide analogues in chronic hepatitis B treatment.核苷和核苷酸类似物在慢性乙型肝炎治疗中的肝外效应
J Gastroenterol Hepatol. 2014 Mar;29(3):428-34. doi: 10.1111/jgh.12499.
2
Depletion of the cellular antioxidant system contributes to tenofovir disoproxil fumarate - induced mitochondrial damage and increased oxido-nitrosative stress in the kidney.细胞抗氧化系统的耗竭导致替诺福韦二吡呋酯引起的肾脏线粒体损伤和氧化应激增加。
J Biomed Sci. 2013 Aug 19;20(1):61. doi: 10.1186/1423-0127-20-61.
3
Hepatocyte senescence predicts progression in non-alcohol-related fatty liver disease.
在动物模型中给予替诺福韦纳米颗粒后睾丸的组织形态计量学变化。
Discov Nano. 2024 Mar 25;19(1):56. doi: 10.1186/s11671-024-04002-y.
4
Expanding the toolbox of metabolically stable lipid prodrug strategies.拓展代谢稳定脂质前药策略的工具库。
Front Pharmacol. 2023 Jan 6;13:1083284. doi: 10.3389/fphar.2022.1083284. eCollection 2022.
5
Potential Molecular Targets of Tenofovir Disoproxil Fumarate for Alleviating Chronic Liver Diseases a Non-Antiviral Effect in a Normal Mouse Model.富马酸替诺福韦二吡呋酯缓解慢性肝病的潜在分子靶点:正常小鼠模型中的非抗病毒作用
Front Mol Biosci. 2021 Nov 16;8:763150. doi: 10.3389/fmolb.2021.763150. eCollection 2021.
6
ω-Functionalized Lipid Prodrugs of HIV NtRTI Tenofovir with Enhanced Pharmacokinetic Properties.具有增强药代动力学性质的HIV核苷类逆转录酶抑制剂替诺福韦的ω-官能化脂质前药
J Med Chem. 2021 Sep 9;64(17):12917-12937. doi: 10.1021/acs.jmedchem.1c01083. Epub 2021 Aug 30.
7
Prognostic model for nephrotoxicity among HIV-positive Zambian adults receiving tenofovir disoproxil fumarate-based antiretroviral therapy.赞比亚接受替诺福韦二吡呋酯为基础的抗逆转录病毒治疗的 HIV 阳性成人中肾毒性的预后模型。
PLoS One. 2021 Jul 12;16(7):e0252768. doi: 10.1371/journal.pone.0252768. eCollection 2021.
8
Renal Dysfunction and Tubulopathy Induced by High-Dose Tenofovir Disoproxil Fumarate in C57BL/6 Mice.高剂量富马酸替诺福韦二吡呋酯在C57BL/6小鼠中诱导的肾功能障碍和肾小管病变
Healthcare (Basel). 2020 Oct 21;8(4):417. doi: 10.3390/healthcare8040417.
9
Tenofovir disoproxil fumarate induces peripheral neuropathy and alters inflammation and mitochondrial biogenesis in the brains of mice.富马酸替诺福韦二吡呋酯诱导小鼠周围神经病,并改变其大脑中的炎症和线粒体生物发生。
Sci Rep. 2019 Nov 20;9(1):17158. doi: 10.1038/s41598-019-53466-x.
10
Tenofovir and adefovir down-regulate mitochondrial chaperone TRAP1 and succinate dehydrogenase subunit B to metabolically reprogram glucose metabolism and induce nephrotoxicity.替诺福韦和阿德福韦通过下调线粒体伴侣蛋白 TRAP1 和琥珀酸脱氢酶亚基 B 来重塑葡萄糖代谢,并导致肾毒性。
Sci Rep. 2017 Apr 11;7:46344. doi: 10.1038/srep46344.
肝细胞衰老预测非酒精性脂肪性肝病的进展。
J Hepatol. 2013 Mar;58(3):549-56. doi: 10.1016/j.jhep.2012.10.031. Epub 2012 Nov 8.
4
Effect of tenofovir, an antiretroviral drug, on hepatic and renal functional indices of Wistar rats: protective role of vitamin E.抗逆转录病毒药物替诺福韦对Wistar大鼠肝肾功能指标的影响:维生素E的保护作用
J Basic Clin Physiol Pharmacol. 2012 Apr 26;23(2):69-75. doi: 10.1515/jbcpp.2011.0042.
5
Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.富马酸替诺福韦二吡呋酯治疗慢性乙型肝炎。
Expert Rev Gastroenterol Hepatol. 2012 Aug;6(4):413-21. doi: 10.1586/egh.12.19.
6
Cyclin-dependent kinase inhibitor p21(Waf1): contemporary view on its role in senescence and oncogenesis.细胞周期蛋白依赖性激酶抑制剂 p21(Waf1):在衰老和肿瘤发生中的作用的现代观点。
Biochemistry (Mosc). 2012 Jun;77(6):575-84. doi: 10.1134/S000629791206003X.
7
Compared to subcutaneous tenofovir, oral tenofovir disoproxyl fumarate administration preferentially concentrates the drug into gut-associated lymphoid cells in simian immunodeficiency virus-infected macaques.与皮下注射替诺福韦相比,口服替诺福韦富马酸酯在感染猴免疫缺陷病毒的猕猴体内将药物优先集中到肠道相关淋巴样细胞中。
Antimicrob Agents Chemother. 2012 Sep;56(9):4980-4. doi: 10.1128/AAC.01095-12. Epub 2012 Jul 9.
8
The cyclin-dependent kinase inhibitor p21CDKN1A as a target of anti-cancer drugs.细胞周期蛋白依赖性激酶抑制剂 p21CDKN1A 作为抗癌药物的靶点。
Curr Cancer Drug Targets. 2012 Feb;12(2):85-96. doi: 10.2174/156800912799095126.
9
Toxicogenomics and metabolomics of pentamethylchromanol (PMCol)-induced hepatotoxicity.五甲基色醇(PMCol)诱导肝毒性的毒代动力学和代谢组学研究。
Toxicol Sci. 2011 Dec;124(2):487-501. doi: 10.1093/toxsci/kfr238. Epub 2011 Sep 13.
10
Tenofovir nephrotoxicity: 2011 update.替诺福韦肾毒性:2011年更新
AIDS Res Treat. 2011;2011:354908. doi: 10.1155/2011/354908. Epub 2011 Jun 7.